Pioneering Australian Trial Targets ‘Untreatable’ MYC-Driven Cancers
ANU launches a groundbreaking PMR-116 trial targeting MYC-driven prostate, breast, ovarian & blood cancers to tackle previously untreatable tumors.
PMR116
Read More
My Global News: Voices of a New Era
🌍 Stay Ahead, Stay Global 🚀